Signals involved in thymocyte positive and negative selection

Seminars in Immunology

Volumn 11, Issue 4, 1999, Pages 263-272

  Mariathasan, Sanjeev ^a   Jones, Russell G ^a   Ohashi, Pamela S ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Negative selection; Positive selection; Signalling; Thymocytes

Indexed keywords

T LYMPHOCYTE RECEPTOR;

CELL DEATH; CELL INTERACTION; CELL SURVIVAL; REVIEW; THYMOCYTE;

EID: 0033178654     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1999.0182     Document Type: Article

References (105)

1. von Boehmer H. Development and selection of T cells: facts and puzzles. Adv Immunol. 58:1995;87-209.
2. Moore N.C., Owen J.J., Jenkinson E.J. Cellular interactions in thymocyte development. Annu Rev Immunol. 14:1996;73-99.
3. Tonegawa S. A differential-avidity model for T-cell selection. Immunol Today. 15:1994;362-366.
4. Immunol Today. 16:1995;223-225.
5. Hogquist K.A., Bevan M.J. Positive selection of thymocytes. Annu Rev Immunol. 13:1995;93-126.
6. Tanaka Y., Tarazona R., Kioussis D. The agonist-antagonist balance in positive selection. Immunol Today. 18:1997;121-126.
7. Mariathasan S., Ohteki T., Jones R., Bachmann M.F., Ohashi P.S. Selection of the T cell repertoire. Annu Rev Immunol. 17:1999;829-875.
8. Kanner S.B., Hombach J., Ledbetter J.A., Müller W., Killeen N., Rajewsky K. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science. 269:1995;535-537.
9. Johnson R., Pingel J.T., Matthews R.J., Dalton M., Roy G., Chan A.C., Thomas M.L. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science. 272:1996;1173-1176.
10. Fischer K-D, Mlinaric-Rascan I., Siminovitch K.A. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J Exp Med. 184:1996;839-852.
11. Aruffo A., Bajorath J., Buhlmann J.E., Noelle R.J. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol. 14:1996;591-617.
12. Hakem A., Kündig T.M., Matsuyama T., Simard J.J.L., Timms E., Wakeham A., Mittruecker H.W., Griesser H., Takimoto H., Schmits R., Shahinian A., Ohashi P.S., Penninger J.M., Mak T.W. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell. 84:1996;551-562.
13. +thymocytes by two distinct mechanisms differing in their requirement for CD28 costimulation: implications for negative selection in the thymus. J Exp Med. 186:1997;1911-1922.
14. Surh C.D., Sprent J. A role for Fas in negative selection of thymocytes in vivo. J Exp Med. 187:1998;1427-1438.
15. Weiss A. T cell antigen receptor signal transduction. Curr Opin Cell Biol. 9:1997;205-212.
16. Takaki S., Kerner J.D., Perlmutter R.M. Differential signalling by lymphocyte antigen receptors. Annu Rev Immunol. 15:1997;125-154.
17. Love P.E. TCR ζ chain in T cell development and selection. Curr Opin Immunol. 9:1997;380-389.
18. Milia E., Peter A., Jaureguiberry B., Baldari C.T., Palmer E. A motif within the T cell receptor α chain constant region connecting peptide domain controls antigen responsiveness. Immunity. 5:1996;437-447.
19. Shaw A.S., Rothbard J.B., Allen P.M. Partial T cell signaling: Altered phospho-zeta and lack of Zap70 recruitment in APL-induced T cell anergy. Cell. 79:1994;913-922.
20. Wange R.L., Wang J.L., Isakov N., Samelson L.E., Germain R.N. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science. 267:1995;515-518.
21. +T cells in response to antagonist ligands. J Exp Med. 184:1996;149-157.
22. Shaw A.S., Allen P.M. Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. Science. 281:1998;572-575.
23. Williams O., Huby R.D.J., Norton T., Acuto O., Ley S.C., Kioussis D. Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes. Proc Natl Acad Sci USA. 95:1998;8193-8198.
24. Lanzavecchia A. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol Today. 18:1997;299-304.
25. 2+flux correlates with thymocyte selection. J Immunol. 161:1998;6030-6037.
26. Muller S., Dessing M., Lanzavecchia A. Signal extinction and T cell repolarization in T helper cell-antigen-presenting cell conjugates. Eur J Immunol. 26:1996;2012-2016.
27. 1. J Immunol. 159:1997;5253-5263.
28. Müller U., Hausmann B., Palmer E. Positive selection through a motif in the αβ T cell receptor. Science. 281:1998;835-838.
29. Cao Z., Browne C., Alarcon B., Fernandez-Miguel G., Lafaille J., De la Hera A, Tonegawa S., Kappes D.J. CD3δ deficiency arrests development of the αβ but not the γδ T cell lineage. EMBO J. 16:1997;1360-1370.
30. Tran T., Grinberg A., Sommers C.L., Shen H., Love P.E. Role of the multiple T cell receptor (TCR)-ζ chain signaling motifs in selection of the T cell repertoire. J Exp Med. 185:1997;893-900.
31. lck tyrosine kinase activation in T cell receptor-mediated thymic selection. J Exp Med. 184:1996;931-943.
32. fynmutant mice display differential signaling in thymocytes and peripheral T cells. Cell. 70:1992;741-750.
33. fyn. Cell. 70:1992;751-763.
34. fynin T cell development and optimal stimulation of T cells by antigen. J Immunol. 160:1998;5410-5419.
35. Penninger J., Wallace V.A., Kündig T.M., Kawai K., Wakeham A., Timms E., Pfeffer K., Ohashi P.S., Thomas M.L., Furlonger C., Paige C.J., Mak T.W. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell. 74:1993;143-156.
36. +thymocytes, and in B cell maturation. J Exp Med. 183:1996;1707-1718.
37. Saijo K., Niidome T., Kühn R., Aizawa S., Tarakhovsky A. Csk controls antigen receptor-mediated development and selection of T-lineage cells. Nature. 394:1998;901-904.
38. Clements J.L., Fang N., Koretzky G.A. Adaptor proteins in lymphocyte antigen-receptor signaling. Curr Opin Immunol. 10:1998;337-344.
39. +thymic selection in humans lacking Zap-70 kinase. Cell. 76:1994;947-958.
40. Kadlecek T.A., Elder M.E., Filipovich A.H., Kuo W-L, Iwashima M., Parslow T.G., Weiss A. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science. 264:1994;1599-1601.
41. Lin D., Clever J., Chan A.C., Hope T.J., Weiss A., Parslow T.G. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science. 264:1994;1596-1599.
42. Motoyama N., Nakayama K., Senju S., Hatakeyama S., Zhang Q., Chan A.C., Loh D.Y. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature. 376:1995;435-438.
43. Turner M., Mee P.J., Costello P.S., Williams O., Price A.A., Duddy L.P., Furlong M.T., Geahlen R.L., Tybulewicz V.L.J. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature. 378:1995;298-302.
44. Rowley R.B., Pao W., Hayday A., Bolen J.B., Pawson T. Syk tyrosine kinase required for mouse viability and B-cell development. Nature. 378:1995;303-306.
45. Negishi I., Anderson S.J., Chan A.C., Bolen J., Loh D.Y., Pawson T. The Syk and ZAP-70 SH2-containing tyrosine kinases are implicated in pre-T cell receptor signalling. Proc Natl Acad Sci USA. 94:1997;9797-9801.
46. -/-mice by the Syk protein tyrosine kinase. Immunity. 7:1997;369-377.
47. Freeman G.J., Berezovskaya A., Barber D.L., Nadler L.M. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap 1. Science. 278:1997;124-128.
48. Schnall R.G., Venter D.J., Barnett L., Bertoncello I., Thien C.B.F., Langdon W.Y., Bowtell D.D.L. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol Cell Biol. 18:1998;4872-4882.
49. Kole H.K., Hu R-J, Gu H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc Natl Acad Sci USA. 95:1998;15447-15552.
50. Yang B., Ross-Barta S.E., Eliason S.L., Hrstka R.F., Williamson R.A., Koretzky G.A. Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development. Science. 281:1998;416-419.
51. Tsitsikov E., Swinton P., Rathbun G., Alt F.W., Geha R.S. Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76. Cell. 94:1998;229-238.
52. Tedford K., Penninger J.M. Vav links antigen-receptor signaling to the actin cytoskeleton. Semin Immunol. 10:1998;317-327.
53. +thymocytes. Nature. 374:1995;474-476.
54. Mee P.J., Walters A.E., Quinn M.E., Mellor A.L., Zamoyska R., Tybulewicz V.L.J. A requirement for the Rho- family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity. 7:1997;451-460.
55. Fischer K-D, Bachmann M.F., Mariathasan S., Kozieradzki I., Nghiem M.P., Bouchard D., Bernstein A., Ohashi P.S., Penninger J.M. Vav regulates peptide-specific apoptosis in thymocytes. J Exp Med. 188:1998;2099-2111.
56. Yong Y-Y, Nishina H., Tedford K., Marengère L.E.M., Kozieradzki I., Sasaki T., Starr M., Chan G., Gardener S., Nghiem M.P., Bouchard D., Barbacid M., Bernstein A., Penninger J.M. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr Biol. 8:1998;554-562.
57. Graef I.A., Swat W., Chi T., Bautista D.M., Davidson L., Lewis R.S., Alt F.W., Crabtree G.R. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr Biol. 8:1998;563-572.
58. Bunnell S.C., Gurniak C.B., Berg L.J. T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J Exp Med. 187:1998;1721-1727.
59. Littman R. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity. 3:1995;757-769.
60. Schwartz R.H., Pardoll D.M. Effects of cyclosporine A on T cell development and clonal deletion. Science. 241:1988;1655-1658.
61. Lo D., Cheney R., Kanagawa O., Sprent J. Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature. 336:1988;176-179.
62. Sahai B.M., Green D.R. Cyclosporin A inhibits activation-induced cell death in T cell hybridomas and thymocytes. Nature. 339:1989;625-626.
63. Ueda Y., Yamada H., Shores E.W., Singer A., June C.H. In vivo calcium elevations in thymocytes with cell receptors that are specific for self ligand. Science. 257:1992;96-99.
64. Kane L.P., Hedrick S.M. Intracellular signals that mediate thymic negative selection. Immunity. 1:1994;45-56.
65. +thymocytes in vitro. J Immunol. 154:1995;3636-3643.
66. +thymocytes undergoing thymic selection: Requirement of calcineurin activation for thymic positive selection but not negative selection. J Exp Med. 181:1995;927-941.
67. +thymocyte negative selection. J Immunol. 156:1996;4594-4601.
68. rasdistinguishes positive and negative selection in thymocytes. EMBO J. 14:1995;276-285.
69. +thymocytes. Proc Natl Acad Sci USA. 93:1996;4683-4687.
70. Gilmore K.C., Owen M.J. The MAP Kinase Pathway Controls Differentiation from Double-Negative to Double-Positive Thymocyte. Cell. 86:1996;243-251.
71. Forbush K.A., Seger R., Krebs E.G., Perlmutter R.M. S elective requirement for MAP kinase activation in thymocyte differentiation. Nature. 373:1996;620-623.
72. Hogquist K.A., Swan K.A., Bevan M.J., Perlmutter R.M. Positive and negative selection invoke distinct signaling pathways. J Exp Med. 184:1996;9-18.
73. Crompton T., Rosewell I.R., Hayday A.C., Owen M.J. Raf regulates positive selection. Eur J Immunol. 26:1996;2350-2355.
74. Rubin E.M., Chen L-Y, Kaye J. Cutting edge: A role for ras signaling in co-receptor regulation during differentiation of a double-positive thymocyte cell line. J Immunol. 159:1997;5773-5776.
75. Schwarz D.A., Bott C.M., Marshall C.J., Hedrick S.M. The influence of the MAPK pathway on T cell lineage commitment. Immunity. 7:1997;609-618.
76. Moriguchi T., Nishida E., Takahama Y. Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. Immunity. 9:1998;565-574.
77. Yang D.D., Wysk M., Whitmarsh A.J., Davis R.J., Flavell R.A. Defective T cell differentiation in the absence of Jnk1. Science. 282:1998;2092-2095.
78. +T cells to Th1 cells requires MAP kinase JNK2. Immunity. 9:1998;575-585.
79. Kuan C-Y, Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P., Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the JNK3 gene. Nature. 389:1997;865-870.
80. +thymocytes. J Exp Med. 188:1998;1817-1830.
81. Fischer K.D., Radvanyi L., Shahinian A., Hakem R., Rubie E.A., Bernstein A., Mak T.W., Woodgett J.R., Penninger J.M. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature. 385:1997;350-353.
82. Fujikawa K., Ganiatsas S., Yang D., Xavier R.J., Harris N.L., Davidson L., Ferrini R., Davis R.J., Labow M.A., Flavell R.A., Zon L.I., Alt F.W. SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development. Immunity. 8:1998;625-634.
83. Levin S.D., Barton G., Forbush K., Zon L.I., Perlmutter R.M. Analysis of the role of MKK-4/Sek-1 in T cell development and apoptosis. Int Immunol. 10:1998;1077-1082.
84. Kapeller R., Fragoso R., Sen R., Zon L.I., Burakoff S.J. Intrathymic signals in thymocytes are mediated by p38 mitogen-activated protein kinase. J Immunol. 156:1996;4535-4538.
85. Enslen H., Raingeaud J., Recht M., Zapton T., Su M.S.S., Penix L.A., Davis R.J., Flavell R.A. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17:1998;2817-2829.
86. Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis. Science. 270:1995;1326-1331.
87. Patel H.R., Terada N., Aruffo A., Johnson G.L., Gelfand E.W. Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells. J Biol Chem. 270:1995;30823-30828.
88. Kono D.W., Chen L-Y, Rubin E.M., Kaye J. Induction of the early growth response (Egr) family of transcription factors during thymic selection. J Exp Med. 185:1997;731-744.
89. Smith S.W., McLaughlin K.A., Schwartz L.M., Osborne B.A. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature. 281:1994;284.
90. Calnan B., Ngo V., Winoto A. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature. 367:1994;277-281.
91. Szychowski S., Chan F.K.M., Cado D., Winoto A. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity. 3:1995;273-282.
92. Cheng J., Yang Z., Liu C., Su X., Bluethmann H., Mountz J.D. Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self-reactive T cells. J Exp Med. 183:1996;1879-1892.
93. Wesselschmidt R.L., Linette G.P., Kanagawa O., Russell J.H., Milbrandt J. Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science. 269:1995;532-534.
94. +thymocytes. Immunity. 7:1997;243-254.
95. Mora A.L., Scherer D.C., Brockman J.A., Ballard D.W. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kB. J Exp Med. 185:1997;1897-1907.
96. Wilson A., Sordat B., Beermann FJCV. Abnormal T cell development induced by targeted overexpression of IBα J Immunol. 158:1997;5075-5078.
97. DiDonato J., Karin M., Leiden J.M. An essential role for nuclear factor B in promoting double positive thymocyte apoptosis. J Exp Med. 189:1999;145-158.
98. Ho I-C, de la Brousse FC, Hoey T., Grusby M.J., Glimcher L.H. The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity. 9:1998;295-304.
99. Willerford D.M., Grévin D., Davidson L., Camus A., Martin P., Stéhelln D., Alt F.W. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature. 377:1995;635-638.
100. Barton K., Leiden J.M. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature. 377:1995;639-642.
101. Schwarz D.A., Katayama C.D., Hedrick S.M. Schlafen, a new family of growth regulatory genes that affect thymocyte development. Immunity. 9:1998;657-668.
102. Yamazaki T., Arase H., Ono S., Ohno H., Watanabe H., Saito T. A shift from negative to positive selection of autoreactive T cells by the reduced level of TCR signal in TCR-transgenic cd3-deficient mice. J Immunol. 158:1997;1634-1640.
103. Urdahl K.B., Pardoll D.M., Jenkins M.K. Cyclosporin A inhibits positive selection and delays negative selection in αβ TCR transgenic mice. J Immunol. 152:1994;2853-2859.
104. Kisielow P., Miazek A. Positive selection of T cells: rescue from programmed cell death and differentiation require continual engagement of the T cell receptor. J Exp Med. 181:1995;1975-1984.
105. Wilkinson R.W., Anderson G., Owen J.J.T., Jenkinson E.J. Positive selection of thymocytes involves sustained interactions with the thymic microenvironment. J Immunol. 155:1995;5234-5240.